ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML)

Stock Information for Societal CDMO Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Societal CDMO Inc.

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025
ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update
ADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, 2025
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADC Therapeutics Makes Grant to New Employee Under Inducement Plan
ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.